Empyemas require aggressive antimicrobial and surgical management. However, the specifics of antimicrobial therapy have not been studied in clinical trials. The present study examines management and outcomes among a cohort of patients with empyema cared for in a tertiary-care referral hospital over a decade.We retrospectively identified patients hospitalized with empyema from January 2000 through December 2010 at one institution. Patient demographics, laboratory findings, treatments, and patient outcomes were abstracted using a standard form. Data were summarized with standard descriptive statistics.A total of 91 patients were identified. The predominant organisms were viridans group streptococci, which were isolated in 64

作者：Kate, Birkenkamp；John C, O'Horo；Rahul, Kashyap；Ben, Kloesel；Brian D, Lahr；Craig E, Daniels；Francis C, Nichols；Larry M, Baddour

来源：The Journal of infection 2016 年 72卷 5期